(Q37372809)

20 August 2017

The importance of bone marrow examination in determining complete response to therapy in patients with multiple myeloma (English)

1 reference

20 August 2017

1 reference

5

Angela Dispenzieri

1 reference

20 August 2017

4

Robert A Kyle

1 reference

20 August 2017

8

S Vincent Rajkumar

1 reference

20 August 2017

6

Morie A Gertz

1 reference

20 August 2017

2

Shaji Kumar

1 reference

20 August 2017

3

Dirk R Larson

1 reference

20 August 2017

7

Colin L Colby

1 reference

20 August 2017

Cheng E Chee

1

1 reference

PMCID

2756122

20 August 2017

language of work or name

English

0 references

publication date

29 July 2009

1 reference

20 August 2017

1 reference

20 August 2017

114

1 reference

20 August 2017

13

1 reference

20 August 2017

2617-2618

1 reference

International uniform response criteria for multiple myeloma.

20 August 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2756122

Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant

6 September 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2756122

Eliminating the complete response penalty from myeloma response assessment

6 September 2017

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19641191

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Clinically relevant end points and new drug approvals for myeloma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19641191

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1182/BLOOD-2009-01-198788

1 reference

20 August 2017

1 reference

20 August 2017

1 reference

PMCID

2756122